Live data from Hacker News

Oxford University breakthrough on global COVID-19 vaccine

ox.ac.uk

411–420 of 569 posts

Re: Oxford University breakthrough on global COVID-19 vaccine

#411

Earlier quoted context omitted.

Will you then also pay those who put huge effort and expense in to research that was perhaps necessary but didn't lead anywhere?

Most research is government funded

No, it's not. Private R&D spending is at least doouble that of the gov't. Look up the budget of the NIH and compare it with the R&D budget of big pharma.

Re: Oxford University breakthrough on global COVID-19 vaccine

#412
post #204

Earlier quoted context omitted.

To be fair, Johnson & Johnson (a US company) also made a similar pledge to AstraZeneca. These two companies have collectively received more than $1.5 billion from the US government [1]. As I understand it, Pfizer have not taken any federal funding. They do have government purchase agreements, but they are dependent on Pfizer delivering a viable vaccine. Their partner BioNTech received German government funding: Berli…

>These two companies have collectively received more than $1.5 billion from the US government [1]. As I understand it, Pfizer have not taken any federal funding. They do have government purchase agreements, but they So where did Pfizer's capital come from to shoulder these costs? It didn't come out of thin air, they've accumulated capital from somewhere. If not from taxpayers, someone is subsidizing Pfizer's expenses…

Where did Pfizer's capital come from? I don't know, maybe just that they're one of the bigger and more successful companies in human history?

Re: Oxford University breakthrough on global COVID-19 vaccine

#413

Here [1] it says the vaccine was designed mostly over the weekend of 11th Jan 2020. Here we are 10 months later and we know it works. If our knowledge of vaccine design is so good experts can design a vaccine that works over a weekend, what new breakthroughs are required to reduce the time between then and now substantially? A lot of benefit could have been had if we'd been able to get along this path more quickly. […

None. Longitudinal trails are required to assess safety - literally waiting and seeing what happens. There's no other way to assess long term effects on the human system. For the avoidance of any doubt none of the new vaccines have had anything like the proper amount of time for a bare minimum longitudinal trial. Whether you decide to take a vaccine nobody in the world is more than 6 months out on will hopefully be left to personal choice.

Re: Oxford University breakthrough on global COVID-19 vaccine

#414

Earlier quoted context omitted.

> Pay them their costs and not one cent more. I prefer a system where it's very worthwhile for people to risk a lot and work hard to save my life. If it was all about altruism, I doubt a vaccine would be developed for many more years.

Regarding vaccines and altruism I suggest you read up on Jonas Salk, who developed one of the first successful polio vaccines[1] Money quote from linked article: "News of the vaccine's success was first made public on April 12, 1955.[7] Salk was immediately hailed as a "miracle worker", and chose to not patent the vaccine or seek any profit from it in order to maximize its global distribution." [1] https://en.wikiped…

Not to take anything away from his contribution, but it's a bit more complicated with Salk.

The organizations who funded the research looked into the viability of a patent and concluded it wouldn't have succeeded.

"the idea of patenting the vaccine had been directly analyzed and the decision was made not to apply for a patent mainly because it would not result in one."[1]

The distinction should also be made that a patent doesn't necessarily affect global distribution. It just gives the rights to license the technology. They could have patented it and then licensed it for free.

[1]https://www.bio.org/blogs/real-reason-why-salk-refused-paten...

Re: Oxford University breakthrough on global COVID-19 vaccine

#415

Earlier quoted context omitted.

The safety concerns cannot be resolved yet. Effective - yes. Safe? We won’t know for a while. Pandemrix, a flu vaccine, caused a notable uptick in narcolepsy in Sweden, Finland and likely the UK. This was not (and could not) be seen in smaller trial populations. It is not a given that any of the covid vaccines is safe enough. Historically, two cases of rushed vaccines (cutter polio and Gullah barre) were worse than t…

> Pandemrix, a flu vaccine, caused a notable uptick in narcolepsy in Sweden, Finland and likely the UK. "The increased risk of narcolepsy due to vaccination was 1 in 18400 or 0.005%."[1] Considering the fatality and long term disability rate of Covid, and the way testing and safety protocols are done for vaccines, I don't really see how there could be an unknown and unseen risk that would outweigh the risk of contrac…

The risk of death in kids without underlying diseases is is approximately 0. It is not clear that giving (e.g. in the US) 30,000 of these kids narcolepsy is reasonable.

It might be, but it’s not open and shut.

Re: Oxford University breakthrough on global COVID-19 vaccine

#416

It's interesting to layman's eyes that the dosing regime using 1.5 doses is more effective than the one using 2 doses as I would expect the inverse; are there any plausible explanations for this?

One theory is that it's due to the vector. This utilizes an adenovirus (which has been used more commonly in vaccines previously, and is different from the novel mRNA viruses developed by Biontech/Pfizer/Moderna). The thought process is that with a larger initial dose of the vaccine, more immune resistance is built up by the body initially, which then neutralizes some of the booster when its given later.

Re: Oxford University breakthrough on global COVID-19 vaccine

#418

Earlier quoted context omitted.

I thought adenoviral vaccines were also relatively new. Not as new as mRNA which is bleeding edge, but still i think this would be the first time this technique would be approved for human use should it be approved.

The article says adenovirus vaccines have been "researched and used extensively for decades."

That statement is somewhat ambiguous, because there have been vaccines against adenovirus infection available since the 70s, but the use of adenovirus as a vaccine vector (which us different) is fairly new. The latter has not been the case for "decades".

Re: Oxford University breakthrough on global COVID-19 vaccine

#419

Earlier quoted context omitted.

[flagged]

Will you then also pay those who put huge effort and expense in to research that was perhaps necessary but didn't lead anywhere?

These nickle and dime arguments are for "old normal".

The society at large is making huge sacrifices and making painful changes to address this collective problem. Are these companies part of "Human society" or not? If they are party of Humanity, then they can make 'adjustments' as much as we are asked to make adjustments.

Re: Oxford University breakthrough on global COVID-19 vaccine

#420

Earlier quoted context omitted.

I’ve seen this number with some justification being the amortized cost of a successful product, which covers r&d and marketing but also the failed attempts that lead nowhere in between. There are plenty of 50-100M pharma startups; they wouldn’t exist if your number was right.

90% of start ups fail, so the numbers in that case would be about correct.

No.

GP said idea to product costs 1B just for r&d. That and 1B amortized over failures (and including marketing) cannot be true at the same time unless there are no failed attempts and unless marketing cost is zero.

Post reply on HN